Evidence map›Paper›PMID 40762724›Full record

ArticleFamilial cancer2025

Copy number and structural variant analyses of VHL gene using droplet digital PCR and targeted adaptive sampling long-read sequencing.

Shota Kato, Hiroko Terui-Kohbata, Atsushi Kudo, Masafumi Seki, Junko Takita, Tomohiro Morio, Yoshiko Nakano, Motohiro Kato, Masayuki Yoshida, Masatoshi Takagi

Abstract read
PubMed Publisher
In one paragraph

Article in Familial cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shota Kato *Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Hiroko Terui-Kohbata *Department of Medical Genetics, Institute of Science Tokyo, Tokyo, Japan.
Atsushi KudoDepartment of Hepatobiliary and Pancreatic Surgery, Institute of Science Tokyo, Tokyo, Japan.
Masafumi SekiDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Junko TakitaDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Tomohiro MorioDepartment of Pediatrics and Developmental Biology, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Yoshiko NakanoDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Motohiro KatoDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Masayuki YoshidaDepartment of Medical Genetics, Institute of Science Tokyo, Tokyo, Japan.
Masatoshi TakagiDepartment of Pediatrics and Developmental Biology, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan. m.takagi.ped@tmd.ac.jp.

Funding

Japan Agency for Medical Research and Development 24ek0109746h0001Japan Agency for Medical Research and Development (AMED) JP24ck0106990
6 · The paper itself

Abstract

Von Hippel–Lindau (VHL) disease is an inherited tumor syndrome characterized by tumors and cysts in various organs, such as the eyes, pancreas, adrenal glands, and kidneys. VHL is caused by pathogenic variants in the VHL gene, which plays a critical role in blood vessel formation. Although direct sequencing is effective for detecting VHL gene variants, approximately 30% of patients with VHL disease harbor large deletions, necessitating alternative detection techniques such as multiplex ligation-dependent probe amplification (MLPA) and comparative genomic hybridization (CGH) arrays. In this study, we evaluated the clinical utility of droplet digital polymerase chain reaction (ddPCR) and targeted adaptive sampling long-read sequencing (TAS-LRS) for VHL gene deletion analysis. In cases of complex deletions, adaptive sampling was shown to be a powerful method capable of precisely identifying the exact sequence alterations. Our findings suggest that these novel techniques enable rapid and accurate detection of gene deletions in clinical genetic testing.

Indexed as

DNA Copy Number VariationsPolymerase Chain Reactionvon Hippel-Lindau DiseaseVon Hippel-Lindau Tumor Suppressor ProteinGene DeletionHumansSequence Analysis, DNAVHL protein, humanVon Hippel-Lindau Tumor Suppressor ProteinDroplet digital PCRTargeted adaptive sampling long-read sequencingVHLVon Hippel–Lindau

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.